Life ScienceCompany
The Medicines Company M&A Summary
The Medicines Company has acquired 6 companies of its own. A total of 3 acquisitions came from private equity firms. It has also divested 2 assets.
The Medicines Company’s largest acquisition to date was in 2013, when it acquired ProFibrix B.V. for $230M. It’s largest disclosed sale occurred in 2017, when it sold The Medicines Company - Infectious Disease Business to Melinta Therapeutics for $270M. The Medicines Company has acquired in 2 different US states, and 3 countries. The Company’s most targeted sectors include life science (67%) and medical products (34%).
The Medicines Company Ownership
Who owns The Medicines Company?
The Medicines Company is owned by Novartis AG. It was acquired on November 24, 2019.
The Medicines Company Business Overview
Where is The Medicines Company headquartered?
The Medicines Company is headquartered in Parsippany, New Jersey.
What is The Medicines Company’s revenue?
The Medicines Company disclosed revenue of 6M USD for 2018 and 45M USD for 2017.
How many employees does The Medicines Company have?
The Medicines Company has 62 employees.
What sector is The Medicines Company in?
The Medicines Company is a life science company.
When was The Medicines Company founded?
The Medicines Company was founded in 1996.
M&A Summary
-
M&A Total Activity8
- M&A Buy Activity6
- M&A Sell Activity2
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 5
- M&A Advisors 6
Unlimited Searches
